Table 2.
Patient No. | Age (years) | Mutation Status | Surveillance Round (No.) | BI-RADS Category |
Histology | TNM Stage |
Tumor Grade | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
US | MG | MRI | T | N | M | ||||||
1 | 45 | BRCA2 | 1 | 1 | 4 | 3 | IDC | mic | 0 | 0 | 3 |
2 | 34 | UV | 1 | 1 | 1 | 4 | DCIS | is | 0 | 0 | 2 |
3 | 55 | UV | 1 | 3 | 3 | 4 | DCIS | is | 0 | 0 | 2 |
4 | 38 | BRCA1 | 1 | 4 | 4 | 4 | DCIS | is | 0 | 0 | 2 |
5 | 55 | Unknown | 1 | 4 | 4 | 5 | DCIS | is | 0 | 0 | 1 |
6 | 55 | Unknown | 1 | 4 | 4 | 5 | DCIS | is | 0 | 0 | 1 |
7 | 52 | UV | 1 | 4 | 1 | 4 | DCIS | is | 0 | 0 | 3 |
8 | 31 | Unknown | 1 | 1 | 1 | 4 | DCIS | is | 0 | 0 | 2 |
9 | 48 | Wild type | 1 | 1 | 4 | 4 | DCIS | is | 0 | 0 | 1 |
10 | 35 | BRCA1 | 1 | 5 | 5 | 5 | IDC | 2 | 1b | 0 | 3 |
11 | 42 | BRCA1 | 1 | 1 | 1 | 4 | IDC | 1b | 0 | 0 | 3 |
12 | 62 | Unknown | 1 | 1 | 1 | 4 | IDC | 1b | 0 | 0 | 2 |
13 | 48 | UV | 1 | 1 | 1 | 5 | IDC | 2 | 0 | 0 | 3 |
14 | 41 | Unknown | 1 | 5 | 1 | 5 | IDC | 2 | 1a | 0 | 2 |
15 | 66 | Wild type | 1 | 5 | 1 | 5 | IDC | 1c | 0 | 0 | 2 |
16 | 43 | Unknown | 1 | 1 | 1 | 4 | IDC | 1b | 0 | 0 | 1 |
17 | 63 | Wild type | 1 | 5 | 5 | 4 | IDC | 1c | 0 | 0 | 2 |
18 | 53 | BRCA1 | 1 | 1 | 1 | 3 | IDC | 1a | 0 | 0 | 1 |
19 | 27 | Unknown | 1 | 5 | 5 | 5 | Metastasis from ovarian cancer | NA | NA | NA | NA |
20 | 49 | UV | 2 | 2 | 2 | 4 | DCIS | is | 0 | 0 | 1 |
21 | 41 | BRCA2 | 2 | 1 | 1 | 4 | IDC | mic | 0 | 0 | 3 |
22 | 53 | Wild type | 2 | 1 | 1 | 4 | DCIS | is | 0 | 0 | 2 |
23 | 50 | Wild type | 2 | 1 | 1 | 4 | DCIS | is | 0 | 0 | 3 |
24 | 46 | BRCA2 | 2 | 1 | 4 | 4 | DCIS | is | 0 | 0 | 2 |
25 | 36 | BRCA1 | 2 | 4 | 4 | 5 | IDC | 1b | 0 | 0 | 3 |
26 | 64 | UV | 2 | 2 | 1 | 4 | IDC | 1a | 0 | 0 | 1 |
27 | 36 | UV | 3 | 1 | 1 | 4 | IDC | mic | 0 | 0 | 3 |
28 | 42 | BRCA2 | 3 | 2 | 2 | 4 | DCIS | is | 0 | 0 | 2 |
29 | 43 | UV | 3 | 1 | 4 | 4 | IDC | mic | 0 | 0 | 3 |
30 | 42 | BRCA2 | 3 | 2 | 2 | 4 | IDC | 1a | 0 | 0 | 2 |
31 | 62 | UV | 3 | 4 | 4 | 4 | IDC | 1c | 0 | 0 | 3 |
32 | 47 | UV | 3 | 4 | 1 | 4 | IDC | 1c | 1a | 0 | 2 |
33 | 32 | BRCA1 | 3 | 1 | 1 | 4 | IDC | 1c | 0 | 0 | 2 |
34 | 62 | Wild type | 3 | 1 | 4 | 3 | Mucinous IDC recurrence | n/a | 0 | 0 | 2 |
35 | 41 | UV | 4 | 2 | 2 | 4 | IDC | 1b | 0 | 0 | 2 |
36 | 80 | BRCA2 | 4 | 5 | 5 | 4 | IDC | 1c | 0 | 0 | 3 |
37 | 43 | BRCA1 | 4 | 5 | 5 | 5 | Medullary carcinoma | 2 | 0 | 0 | 3 |
38 | 48 | BRCA1 | 5 | 2 | 2 | 4 | IDC | 1b | 0 | 0 | 3 |
39 | 55 | BRCA1 | 7 | 4 | 1 | 4 | DCIS | is | 0 | 0 | 3 |
40 | 38 | BRCA1 | 5 (interval) | 2 | 2 | 1 | Medullary carcinoma | 1c | 0 | 0 | 3 |
Abbreviations: BI-RADS, Breast Imaging and Reporting Data System; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; is, in situ; M, metastasis; MG, mammography; mic, microinvasion; MRI, magnetic resonance imaging; N, node status; NA, not applicable; T, tumor; US, ultrasound; UV, unclassified variant.